Education
About Us
Working with TipRanks
Follow Us
Pressure Biosciences (PBIO)
OTHER OTC:PBIO
PBIO Stock Chart & Stats
$0.04
<$0.01(30.00%)
At close: 4:00 PM EST
$0.04
<$0.01(30.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.03
Previous CloseN/A
Volume28.50K
Average Volume (3M)1.17K
Market Cap
$36.87K
Enterprise ValueN/A
Total Cash (Recent Filing)$14.25K
Total Debt (Recent Filing)$29.19M
Price to Earnings (P/E)―
Beta21.50
Next Earnings
Aug 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,967,083
10 Day Avg. Volume345
30 Day Avg. Volume1,173
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-0.24
Price to Sales (P/S)3.89
P/FCF Ratio-2.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pressure Biosciences News
PBIO FAQ
What was Pressure Biosciences’s price range in the past 12 months?
Pressure Biosciences lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Pressure Biosciences’s market cap?
Pressure Biosciences’s market cap is $36.87K.
When is Pressure Biosciences’s upcoming earnings report date?
Pressure Biosciences’s upcoming earnings report date is Aug 14, 2025 which is 82 days ago.
How were Pressure Biosciences’s earnings last quarter?
Currently, no data Available
Is Pressure Biosciences overvalued?
According to Wall Street analysts Pressure Biosciences’s price is currently Overvalued.
Does Pressure Biosciences pay dividends?
Pressure Biosciences does not currently pay dividends.
What is Pressure Biosciences’s EPS estimate?
Pressure Biosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pressure Biosciences have?
Pressure Biosciences has 40,967,083 shares outstanding.
What happened to Pressure Biosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pressure Biosciences?
Currently, no hedge funds are holding shares in PBIO
Company Description
Pressure Biosciences
Pressure BioSciences, Inc. (PBIO) is a life sciences company focused on developing and commercializing innovative technologies and products for the global healthcare, biotechnology, pharmaceutical, and food industries. The company specializes in high-pressure-based scientific instruments and associated consumables, which are used for various applications, including biomarker discovery, drug design, food safety, and pathogen inactivation. PBIO's core technology platform, Pressure Cycling Technology (PCT), enables the manipulation of biomolecules and cellular structures in a unique manner, enhancing the quality and efficiency of scientific research and development.
Technical Analysis
Sintx Technologies
―
Streamex
―
INVO Fertility
―
Vivos Therapeutics
―
Bluejay Diagnostics
―
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---